Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Glens Falls, NY MSA — September 2026
Glens Falls wages lag national life sci pay despite tightening quality talent market.
Validation Engineer advertised pay climbed to $105,849 locally while Clinical Data Manager pay fell to $123,978, against a metro average weekly wage still 26% below the U.S. figure.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Metro unemployment rate: 3.4% — Up from 2.70% a year ago; NYS at 4.3%
- Average weekly wage, Glens Falls: $1,231 — vs. $1,654 U.S. average (Q1 2026)
- NY pharma/biotech employment: 23,643 jobs — Record high, Aug 2026, despite hiring pullback
- National biopharma postings: -39% YoY — BioSpace, Sept 2026, selective hiring environment
Key takeaways
Local wage gap widens the build-vs-outsource calculus.
Average weekly wages in Glens Falls sit nearly 26% below the national figure, which helps on routine roles but does little when competing for cell/gene CMC or regulatory specialists commanding six-figure premiums nationally. Leaders weighing in-house manufacturing expansion against CDMO partnerships should factor in whether local pay structures can realistically attract these scarcer skill sets.
Validation Engineer pay climbs while Clinical Data Manager pay softens.
Metro advertised pay for Validation Engineer rose to $105,849, a significant increase tracking the national trend ($108,377, also up), consistent with sustained manufacturing and quality investment in the Capital Region. Clinical Data Manager pay fell to $123,978 locally, mirroring a national decline — a divergence that suggests manufacturing-adjacent quality roles are tightening faster than clinical data functions here.
A national hiring pause is a local recruiting opportunity.
BioSpace postings down 39% year-over-year and layoffs at BioMarin and Bristol Myers suggest displaced specialized talent may be more open to smaller-market employers than in recent years. Glens Falls employers competing against Albany, Boston, and the broader Capital Region may find this a rare moment to recruit regulatory or quality talent without matching peak-market compensation.
Nonfarm job contraction masks selective sector strength.
Total nonfarm employment in the metro fell 0.4% year-over-year even as private sector jobs grew 0.9% and leisure/hospitality added 500 positions — a pattern consistent with public-sector softness rather than broad economic weakness. Life sci and healthcare employers should not read headline job losses as reduced competition for scientific or clinical talent.
Median advertised pay by role — Glens Falls, NY MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $82,152 | $121,403 | $148,970 | Moderate increase | $131,354 |
| Clinical Research Associate * | $72,812 | $97,647 | $102,276 | Significant increase | $90,956 |
| Lab Technician * | $40,114 | $46,904 | $50,189 | Stable | $47,402 |
| Regulatory Affairs Specialist * | $70,044 | $96,238 | $116,373 | Moderate decline | $104,000 |
| Clinical Data Manager * | $103,367 | $123,978 | $136,385 | Significant decline | $123,031 |
| Biostatistician * | $109,100 | $140,725 | $175,000 | Moderate increase | $133,322 |
| Validation Engineer * | $95,728 | $105,849 | $119,600 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Glens Falls MSA unemployment held at 3.4% in August, down from a softer 3.6% June reading but still above last year's 2.70% — a sign that the metro's historically tight labor supply is loosening modestly even as nonfarm payrolls contracted 0.4% year-over-year through December 2025. Against an average weekly wage of just $1,231 versus the $1,654 U.S. average, local employers compete for scientific and clinical talent against metros paying meaningfully more, even as statewide pharma/biotech employment hit a record 23,643 jobs and BioSpace postings fell 39% year-over-year, signaling a national pullback that gives Glens Falls employers some relief on competitive pressure from larger hubs.
What it means
Soft wage levels locally mean Glens Falls life sci and med device employers — anchored by BD/Becton Dickinson, Medline/NAMIC, and the region's hospital systems — cannot rely on geography alone to retain CMC, quality, or regulatory talent when national premiums for those specialties (Director CMC/Process Development at $220K–$520K, VP Regulatory Affairs at $320K–$580K) continue climbing. Declining national postings activity creates a narrow window to recruit displaced specialized talent before larger hubs resume hiring, but local wage levels nearly 26% below the U.S. average suggest compensation structures may need targeted adjustment for scarce credentialed roles rather than across-the-board increases. Consider reviewing compensation for quality, regulatory, and CMC-adjacent positions specifically, where national scarcity premiums are least likely to be offset by local labor market softening.
Looking ahead
Worth watching: Glens Falls unemployment has ticked up from 2.70% a year ago to 3.4%, a trend worth tracking against NYS's overall decline to 4.3% in August. If the metro's rate continues rising against the state's downward trajectory, local talent supply dynamics may diverge meaningfully from state-level planning assumptions.
Emerging pressure point: New York WARN filings show healthcare and manufacturing among the top three affected industries statewide, with 53 and 49 notices respectively. Watch whether any Capital Region facility announcements surface, which could add quality or regulatory-adjacent talent to the local candidate pool.
Expected: National biopharma postings have turned negative year-over-year even as 64% of surveyed organizations report active recruiting — a tension likely to persist through Q4. Expect continued selective hiring locally concentrated in manufacturing, quality, and CMC rather than broad-based headcount expansion.
Potential inflection point: Validation Engineer advertised pay is rising both locally and nationally while Clinical Data Manager pay falls on both fronts. If this divergence continues through Q4, it may signal a durable reallocation of compensation budgets toward manufacturing-adjacent quality roles at the expense of clinical operations functions.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.